About this trial
Heart failure is a severe heart disease, where the heart's ability to pump blood is unsatisfactory. The consequence is a high risk of hospitalization and death. Heart failure is treated with medicine which relieves symptoms and slows down the disease progression. This medical treatment needs routine adjustment, but in many cases, this adjustment is not done timely, which results in life treating conditions where the patients need acute hospitalization. Remote health monitoring of HF patients has the potential to ensure timely adjustment. However, only sensors placed inside the blood vessels of the lung, have been shown effective. The disadvantage is that the placement of the sensor requires surgery. This makes the method costly and poses a risk for the patient. The aim of the current project is to develop a small intelligent patch, which can measure the heart's function from the outside of the body. The method will be low-cost, simple to use and will not pose a risk to the patient.
Eligibility criteria
Qualifiers
NYHA Class II or higher
18-90 years old
Disqualifiers
Pregnancy
Drug addiction defined as the use of cannabis, opioids, or other drugs
Mechanical heart valves
In dialysis
Trial design
Treatments tested in this trial
- Continuous monitroing
Treatment groups
Sponsors and collaborators
Aalborg University
Lead sponsor
Aalborg University Hospital
Collaborator
Copenhagen University Hospital at Herlev
Collaborator